Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report

Congenital generalized lipodystrophy type 4 (CGL4) is a rare disease caused by mutations in the gene polymerase I and transcript release factor (PTRF), the main symptoms of which are systemic reductions in adipose tissue and muscular dystrophy. The strategy of treating CGL4 is to improve the insulin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Pediatr Endocrinol
Main Authors: Takeyari, Shinji, Takakuwa, Satoshi, Miyata, Kei, Yamamoto, Kenichi, Nakayama, Hirofumi, Ohata, Yasuhisa, Fujiwara, Makoto, Kitaoka, Taichi, Kubota, Takuo, Namba, Noriyuki, Sakai, Norio, Ozono, Keiichi
Format: Artigo
Sprog:Inglês
Udgivet: The Japanese Society for Pediatric Endocrinology 2019
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6356095/
https://ncbi.nlm.nih.gov/pubmed/30745727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.28.1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker